FDA issued draft guidance addressing grandfathering exemptions from the package identification requirements of the Drug Supply Chain Security Act (DSCSA). The guidance specifies the circumstances under which packages and homogenous cases of products shall meet the grandfathering exemption criteria. Comments may be submitted according to the Federal Register announcement until January 26, 2018.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
